INTRODUCTION: The development of metabolic syndrome-associated renal dysfunction is exacerbated by a number of factors including dyslipidemia, ectopic deposition of lipids and their toxic metabolites, impairment of lipid metabolism, and insulin resistance. Renal dysfunction is also affected by the production of proinflammatory and profibrotic factors secreted from adipose tissue, which can in turn directly impair kidney cells and potentiate insulin resistance. In this study, we investigated the manifestation of renal lipid accumulation and its effect on renal dysfunction in a model of metabolic syndrome-the hereditary hypertriglyceridemic rat (HHTg)-by assessing microalbuminuria and targeted urinary proteomics. Male Wistar control rats and HHTg rats were fed a standard diet and observed over the course of ageing at 3, 12, and 20 months of age. RESULTS: Chronically elevated levels of triglycerides in HHTg rats were associated with increased levels of NEFA during OGTT and over a period of 24 hours (+80%, P < 0.01). HHTg animals exhibited qualitative changes in NEFA fatty acid composition, represented by an increased proportion of saturated fatty acids (P < 0.05) and a decreased proportion of n-3 PUFA (P < 0.01). Ectopic lipid deposition in the kidneys of HHTg rats-triglycerides (+30%) and cholesterol (+10%)-was associated with markedly elevated microalbuminuria as ageing increased, despite the absence of microalbuminuria at the young age of 3 months in these animals. According to targeted proteomic analysis, 3-month-old HHTg rats (in comparison to age-matched controls) exhibited increased urinary secretion of proinflammatory parameters (MCP-1, IL-6, IL-8, P < 0.01) and decreased urinary secretion of epidermal growth factor (EGF, P < 0.01) before manifestation of microalbuminuria. Elevation in the urinary secretion of inflammatory cytokines can be affected by increased relative expression of MCP-1 in the renal cortex (P < 0.05). CONCLUSIONS: Our results confirm dyslipidemia and ectopic lipid accumulation to be key contributors in the development of metabolic syndrome-associated renal dysfunction. Assessing urinary secretion of proinflammatory cytokines and epidermal growth factor can help in detecting early development of metabolic syndrome-associated renal dysfunction.

Centre for Experimental Medicine Institute for Clinical and Experimental Medicine 14021 Prague Czech Republic

Czech Centre for Phenogenomics Institute of Molecular Genetics of the Czech Academy of Sciences 25250 Vestec Czech Republic

Czech University of Life Sciences 16500 Prague Czech Republic

Department of Chemistry University College London London WC1H 0AJ UK

Zobrazit více v PubMed

Huh J. H., Yadav D., Kim J. S., et al. An association of metabolic syndrome and chronic kidney disease from a 10-year prospective cohort study. Metabolism. 2017;67:54–61. doi: 10.1016/j.metabol.2016.11.003. PubMed DOI

Zhang X., Lerman L. O. The metabolic syndrome and chronic kidney disease. Translational Research. 2017;183:14–25. doi: 10.1016/j.trsl.2016.12.004. PubMed DOI PMC

Shi M., Ma L., Fu P. . Role of fatty acid binding protein 4 (FABP4) in kidney disease. Current Medicinal Chemistry. 2018;25 doi: 10.2174/0929867325666181008154622. PubMed DOI

Guebre-Egziabher F., Alix P. M., Koppe L., et al. Ectopic lipid accumulation: a potential cause for metabolic disturbances and a contributor to the alteration of kidney function. Biochimie. 2013;95(11):1971–1979. doi: 10.1016/j.biochi.2013.07.017. PubMed DOI

Escasany E., Izquierdo-Lahuerta A., Medina-Gomez G. Underlying mechanisms of renal lipotoxicity in obesity. Nephron. 2019;143(1):28–32. doi: 10.1159/000494694. PubMed DOI

Sieber J., Jehle A. W. Free fatty acids and their metabolism affect function and survival of podocytes. Frontiers in Endocrinology. 2014;5 doi: 10.3389/fendo.2014.00186. PubMed DOI PMC

Macisaac R. J., Ekinci E. I., Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. American Journal of Kidney Diseases. 2014;63(2):S39–S62. doi: 10.1053/j.ajkd.2013.10.048. PubMed DOI

Hou N., Han F., Wang M., et al. Perirenal fat associated with microalbuminuria in obese rats. International Urology and Nephrology. 2014;46(4):839–845. doi: 10.1007/s11255-014-0656-7. PubMed DOI

Lindhardt M., Persson F., Zürbig P., et al. Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study. Nephrology Dialysis Transplantation. 2017;32(11):gfw292–gf1873. doi: 10.1093/ndt/gfw292. PubMed DOI

Vrana A., Kazdova L. The hereditary hypertriglyceridemic nonobese rat: an experimental model of human hypertriglyceridemia. Transplantation Proceedings. 1990;22(6):p. 2579. PubMed

Kahleova H., Malinska H., Kazdova L., et al. The effect of meal frequency on the fatty acid composition of serum phospholipids in patients with type 2 diabetes. Journal of the American College of Nutrition. 2015;35(4):317–325. doi: 10.1080/07315724.2015.1046197. PubMed DOI

Contois J. H., Hartigan C., Rao L. V., Snyder L. M., Thompson M. J. Analytical validation of an HPLC assay for urinary albumin. Clinica Chimica Acta. 2006;367(1-2):150–155. doi: 10.1016/j.cca.2005.12.002. PubMed DOI

Kačerová T., Novotný P., Boroň J., Kačer P. Molecular diagnostics of pulmonary diseases based on analysis of exhaled breath condensate. In: Ghousia G., editor. Biomarker: Indicator of Abnormal Physiological Process. Zagreb, Croatia: InTech Publishing; 2018. pp. 141–168. DOI

Neprasova M., Maixnerova D., Novak J., et al. Toward noninvasive diagnosis of IgA nephropathy: a pilot urinary metabolomic and proteomic study. Disease Markers. 2016;2016(9):9. doi: 10.1155/2016/3650909.3650909 PubMed DOI PMC

Lennon R., Pons D., Sabin M. A., et al. Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. Nephrology Dialysis Transplantation. 2009;24(11):3288–3296. doi: 10.1093/ndt/gfp302. PubMed DOI PMC

Mima A., Ohshiro Y., Kitada M., et al. Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney International. 2011;79(8):883–896. doi: 10.1038/ki.2010.526. PubMed DOI PMC

Klein-Platat C., Drai J., Oujaa M., Schlienger J. L., Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. The American Journal of Clinical Nutrition. 2005;82(6):1178–1184. doi: 10.1093/ajcn/82.6.1178. PubMed DOI

Floegel A., Stefan N., Yu Z., et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62(2):639–648. doi: 10.2337/db12-0495. PubMed DOI PMC

Bobulescu I. A. Renal lipid metabolism and lipotoxicity. Current Opinion in Nephrology and Hypertension. 2010;19(4):393–402. doi: 10.1097/MNH.0b013e32833aa4ac. PubMed DOI PMC

Izquierdo-Lahuerta A., Martinez-Garcia C., Medina-Gomez G. Lipotoxicity as a trigger factor of renal disease. Journal of Nephrology. 2016;29(5):603–610. doi: 10.1007/s40620-016-0278-5. PubMed DOI

Iwai T., Kume S., Chin-Kanasaki M., et al. Stearoyl-CoA desaturase-1 protects cells against lipotoxicity-mediated apoptosis in proximal tubular cells. International Journal of Molecular Sciences. 2016;17(11):p. 1868. doi: 10.3390/ijms17111868. PubMed DOI PMC

Fan Y., Lee K., Wang N., He J. C. The role of endoplasmic reticulum stress in diabetic nephropathy. Current Diabetes Reports. 2017;17(3) doi: 10.1007/s11892-017-0842-y. PubMed DOI

Zicha J., Pecháňová O., Čačányiová S., et al. Hereditary hypertriglyceridemic rat: a suitable model of cardiovascular disease and metabolic syndrome? Physiological Research. 2006;55(1):S49–S63. PubMed

Sarafidis P. A., Ruilope L. M. Insulin resistance, microalbuminuria, and chronic kidney disease. Current Hypertension Reports. 2008;10(4):249–251. doi: 10.1007/s11906-008-0046-6. PubMed DOI

Raikou V., Gavriil S. Metabolic syndrome and chronic renal disease. Diseases. 2018;6(1):p. 12. doi: 10.3390/diseases6010012. PubMed DOI PMC

Fioretto P., Steffes M. W., Mauer M. Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes. 1994;43(11):1358–1364. doi: 10.2337/diab.43.11.1358. PubMed DOI

Cherney D. Z., Scholey J. W., Daneman D., et al. Urinary markers of renal inflammation in adolescents with type 1 diabetes mellitus and normoalbuminuria. Diabetic Medicine. 2012;29(10):1297–1302. doi: 10.1111/j.1464-5491.2012.03651.x. PubMed DOI

Nadkarni G. N., Rao V., Ismail-Beigi F., et al. Association of urinary biomarkers of inflammation, injury, and fibrosis with renal function decline: the ACCORD trial. Clinical Journal of the American Society of Nephrology. 2016;11(8):1343–1352. doi: 10.2215/CJN.12051115. PubMed DOI PMC

Decleves A. E., Sharma K. Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis. Current Opinion in Nephrology and Hypertension. 2015;24(1):28–36. doi: 10.1097/MNH.0000000000000087. PubMed DOI PMC

Verhave J. C., Bouchard J., Goupil R., et al. Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. Diabetes Research and Clinical Practice. 2013;101(3):333–340. doi: 10.1016/j.diabres.2013.07.006. PubMed DOI

Satirapoj B., Dispan R., Radinahamed P., Kitiyakara C. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease. BMC Nephrology. 2018;19(1):p. 246. doi: 10.1186/s12882-018-1043-x. PubMed DOI PMC

Torres D. D., Rossini M., Manno C., et al. The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney International. 2008;73(3):327–333. doi: 10.1038/sj.ki.5002621. PubMed DOI

Betz B. B., Jenks S. J., Cronshaw A. D., et al. Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes. Kidney International. 2016;89(5):1125–1135. doi: 10.1016/j.kint.2016.01.015. PubMed DOI

Van J. A. D., Scholey J. W., Konvalinka A. Insights into diabetic kidney disease using urinary proteomics and bioinformatics. Journal of the American Society of Nephrology. 2017;28(4):1050–1061. doi: 10.1681/ASN.2016091018. PubMed DOI PMC

Rehman K., Akash M. S. H., Liaqat A., Kamal S., Qadir M. I., Rasul A. Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Critical Reviews in Eukaryotic Gene Expression. 2017;27(3):229–236. doi: 10.1615/CritRevEukaryotGeneExpr.2017019712. PubMed DOI

Lamacchia O., Nicastro V., Camarchio D., et al. Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients. Nephrology Dialysis Transplantation. 2011;26(3):892–898. doi: 10.1093/ndt/gfq522. PubMed DOI

Sun X., Han F., Miao W., Hou N., Cao Z., Zhang G. Sonographic evaluation of para- and perirenal fat thickness is an independent predictor of early kidney damage in obese patients. International Urology and Nephrology. 2013;45(6):1589–1595. doi: 10.1007/s11255-013-0404-4. PubMed DOI

Martínez-García C., Izquierdo-Lahuerta A., Vivas Y., et al. Renal lipotoxicity-associated inflammation and insulin resistance affects actin cytoskeleton organization in podocytes. PLoS One. 2015;10(11):p. e0142291. doi: 10.1371/journal.pone.0142291. PubMed DOI PMC

Beneficial Effect of Fenofibrate in Combination with Silymarin on Parameters of Hereditary Hypertriglyceridemia-Induced Disorders in an Animal Model of Metabolic Syndrome

Female prediabetic rats are protected from vascular dysfunction: the role of nitroso and sulfide signaling

Empagliflozin alters lipid metabolism in the myocardium and liver in a prediabetes model with severe dyslipidemia

The Effect of Ovariectomy and Estradiol Substitution on the Metabolic Parameters and Transcriptomic Profile of Adipose Tissue in a Prediabetic Model

The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model

Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model

The Vasoactive Role of Perivascular Adipose Tissue and the Sulfide Signaling Pathway in a Nonobese Model of Metabolic Syndrome